{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:57:15Z","timestamp":1791835035111,"version":"4.3.4"},"reference-count":96,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.heliyon.2023.e17298","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T03:25:36Z","timestamp":1687922736000},"page":"e17298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Characterization of monoclonal gammopathy of undetermined significance progression to multiple myeloma through meta-analysis of GEO data"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4999-9372","authenticated-orcid":false,"given":"Jihad","family":"Aljabban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9381-0456","authenticated-orcid":false,"given":"Sharjeel","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7239-3905","authenticated-orcid":false,"given":"Saad","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Aljabban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cottini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Panahiazr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0990-4674","authenticated-orcid":false,"given":"Dexter","family":"Hadley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2023.e17298_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.heliyon.2023.e17298_bib2","article-title":"Cancer statistics","volume":"2020","author":"Siegel","year":"2020","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17298_bib3","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood.V99.5.1745","article-title":"Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells","volume":"99","author":"Zhan","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17298_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nyas.13038","article-title":"Multiple myeloma in the marrow: pathogenesis and treatments","volume":"1364","author":"Fairfield","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.heliyon.2023.e17298_bib5","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e17298_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1852517","article-title":"Inflammatory and anti-inflammatory equilibrium, proliferative and antiproliferative balance: the role of cytokines in multiple myeloma","author":"Musolino","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.heliyon.2023.e17298_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12307-011-0086-3","article-title":"The immune microenvironment of myeloma. Cancer Microenvironment","volume":"4","author":"Noonan","year":"2011","journal-title":"Off. J. Int. Cancer Microenviron. Soc."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17298_bib8","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI66517","article-title":"BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression","volume":"123","author":"Roccaro","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e17298_bib9","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/sj.leu.2402295","article-title":"Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications","volume":"15","author":"Gupta","year":"2001","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17298_bib10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood.V87.3.1104.bloodjournal8731104","article-title":"Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B","volume":"87","author":"Chauhan","year":"1996","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17298_bib11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood-2014-03-562439","article-title":"Bone marrow stromal cell\u2013derived exosomes as communicators in drug resistance in multiple myeloma cells","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"9200","key":"10.1016\/j.heliyon.2023.e17298_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(00)00019-2","article-title":"New insights into role of microenvironment in multiple myeloma","volume":"355","author":"Tricot","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17298_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.heliyon.2023.e17298_bib14","doi-asserted-by":"crossref","first-page":"861231","DOI":"10.1155\/2014\/861231","article-title":"Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity","volume":"2014","author":"Olmos","year":"2014","journal-title":"Mediat. Inflamm"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e17298_bib15","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/onc.2016.309","article-title":"Non-canonical NF\u03baB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NF\u03baB pathway","volume":"36","author":"Roy","year":"2016","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17298_bib16","first-page":"5251","article-title":"Thalidomide and its analogues: a review of the potential for immunomodulation of fibrosis diseases and opthalmopathy","volume":"14","author":"Liu","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17298_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1084\/jem.20151724","article-title":"B cell IFN-\u03b3 receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6","volume":"213","author":"Jackson","year":"2016","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e17298_bib18","first-page":"1489","article-title":"CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival","volume":"91","author":"Giuliani","year":"2006","journal-title":"Haematologica"},{"issue":"3\u20134","key":"10.1016\/j.heliyon.2023.e17298_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/10428199509059610","article-title":"Interferon-gamma in multiple myeloma","volume":"18","author":"Palumbo","year":"1995","journal-title":"Leuk. Lymphoma"},{"issue":"6B","key":"10.1016\/j.heliyon.2023.e17298_bib20","first-page":"4115","article-title":"TRAIL expression up-regulated by interferon-gamma via phosphorylation of STAT1 induces myeloma cell death","volume":"26","author":"Miura","year":"2006","journal-title":"Anticancer Res"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e17298_bib21","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3324\/haematol.2017.163766","article-title":"The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma","volume":"102","author":"Mikulasova","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.heliyon.2023.e17298_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41408-020-0284-7","article-title":"Dissecting racial disparities in multiple myeloma","volume":"10","author":"Marinac","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.heliyon.2023.e17298_bib23","doi-asserted-by":"crossref","first-page":"170125","DOI":"10.1038\/sdata.2017.125","article-title":"Precision annotation of digital samples in NCBI\u2019s gene expression omnibus","volume":"4","author":"Hadley","year":"2017","journal-title":"Sci Data"},{"issue":"Issue 4","key":"10.1016\/j.heliyon.2023.e17298_bib24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"Volume 30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics(2014)"},{"key":"10.1016\/j.heliyon.2023.e17298_bib25","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0145-2126(14)70019-0","article-title":"New targets in AML","volume":"38","author":"Yilmaz","year":"2014","journal-title":"Leuk. Res"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17298_bib26","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1309\/AJCPGII1TT4NYOGI","article-title":"Acute myeloid leukemia with t(9;11)(p21-22;q23): common properties of dysregulated Ras pathway signaling and genomic progression characterize de novo and therapy-related cases","volume":"133","author":"Chandra","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17298_bib27","doi-asserted-by":"crossref","first-page":"15278","DOI":"10.1038\/s41598-017-15492-5","article-title":"Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death","volume":"7","author":"Heo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2023.e17298_bib28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1471-2407-10-198","article-title":"Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays","volume":"10","author":"Mahtouk","year":"2010","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17298_bib29","article-title":"The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression","volume":"2","author":"Shilo","year":"2015","journal-title":"Mol Cell Oncol"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e17298_bib30","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1089\/gtmb.2016.0007","article-title":"Genetic association of PARP15 polymorphisms with clinical outcome of acute myeloid leukemia in a Korean population","volume":"20","author":"Lee","year":"2016","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.heliyon.2023.e17298_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature05515","article-title":"Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation","volume":"445","author":"Barreto","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17298_bib32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1023\/A:1009087029511","article-title":"The evolutionarily conserved CKAP2 gene is located in human region 13q14.3 often rearranged in various tumors","volume":"37","author":"Udina","year":"2001","journal-title":"Russ. J. Genet."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17298_bib33","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-2141.2005.05369.x","article-title":"Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo","volume":"128","author":"Zhou","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17298_bib34","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/stem.1035","article-title":"Concise review: role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences","volume":"30","author":"Siddique","year":"2012","journal-title":"Stem Cell"},{"key":"10.1016\/j.heliyon.2023.e17298_bib35","doi-asserted-by":"crossref","first-page":"17530","DOI":"10.1038\/s41598-017-17836-7","article-title":"Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers","volume":"7","author":"Perez-Pe\u00f1a","year":"2017","journal-title":"Sci. Rep."},{"issue":"28","key":"10.1016\/j.heliyon.2023.e17298_bib36","doi-asserted-by":"crossref","first-page":"25226","DOI":"10.18632\/oncotarget.4712","article-title":"Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer","volume":"6","author":"Wen","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17298_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/cancers2020209","article-title":"Thioredoxin and cancer: a role for thioredoxin in all states of tumor oxygenation","volume":"2","author":"Karlenius","year":"2010","journal-title":"Cancers"},{"issue":"21","key":"10.1016\/j.heliyon.2023.e17298_bib38","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1182\/blood-2015-07-659151","article-title":"MUC1-C drives MYC in multiple myeloma","volume":"127","author":"Tagde","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17298_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.15252\/embr.201745497","article-title":"Nup62\u2010mediated nuclear import of p63 in squamous cell carcinoma","volume":"19","author":"Borlido","year":"2018","journal-title":"EMBO Rep"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e17298_bib40","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2443.1998.00206.x","article-title":"AMY\u20101, a novel C\u2010MYC binding protein that stimulates transcription activity of C\u2010MYC","volume":"3","author":"Taira Takahiro","year":"1998","journal-title":"Gene Cell"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e17298_bib41","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1016\/j.celrep.2016.08.024","article-title":"RNF4-Dependent oncogene activation by protein stabilization","volume":"16","author":"Abed","year":"2016","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17298_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.gene.2016.03.051","article-title":"SRPK2 promotes the growth and migration of the colon cancer cells","volume":"586","author":"Wang","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.heliyon.2023.e17298_bib43","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.8026","article-title":"Single cell analysis of multiple myeloma","author":"Ledergor","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17298_bib44","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood-2006-03-012013","article-title":"el al, The THAP\u2013zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB\/E2F cell-cycle target genes","volume":"109","author":"Cayrol","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17298_bib45","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1261\/rna.055699.115","article-title":"Nudt3 is an MRNA decapping enzyme that modulates cell migration","volume":"22","author":"Grudzien-Nogalska Ewa","year":"2016","journal-title":"RNA"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17298_bib46","first-page":"1377","article-title":"Low expression of KCNN3 may affect drug resistance in ovarian cancer","volume":"18","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17298_bib47","article-title":"Classify hyperdiploidy status of multiple myeloma patients using gene expression profiles","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17298_bib48","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2013.08.002","article-title":"Dickkopf-1 is a key regulator of myeloma bone disease: opportunities and challenges for therapeutic intervention","volume":"27","author":"Zhou","year":"2013","journal-title":"Blood Rev"},{"key":"10.1016\/j.heliyon.2023.e17298_bib49","first-page":"37","article-title":"Multiple myeloma, Hematology Am Soc Hematol Educ","author":"Harousseau","year":"2004","journal-title":"Program"},{"key":"10.1016\/j.heliyon.2023.e17298_bib50","doi-asserted-by":"crossref","first-page":"12849","DOI":"10.1038\/ncomms12849","article-title":"PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation","volume":"7","author":"Iwata","year":"2016","journal-title":"Nat. Commun"},{"issue":"40","key":"10.1016\/j.heliyon.2023.e17298_bib51","doi-asserted-by":"crossref","first-page":"33756","DOI":"10.1074\/jbc.M505408200","article-title":"B-aggressive lymphoma family proteins have unique domains that modulate transcription and exhibit poly(ADP-ribose) polymerase activity","volume":"280","author":"Aguiar","year":"2005","journal-title":"J. Biol. Chem"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e17298_bib52","doi-asserted-by":"crossref","first-page":"e51331","DOI":"10.1371\/journal.pone.0051331","article-title":"The anti-proliferative activity of BTG\/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the ccr4-not complex","volume":"E 7","author":"Doidge","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e17298_bib53","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/cdd.2009.16","article-title":"Role of BNIP3 and NIX in cell death, autophagy, and mitophagy","volume":"16","author":"Zhang","year":"2009","journal-title":"Cell Death Differ"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17298_bib54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ni.1823","article-title":"Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry","volume":"11","author":"Travassos","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17298_bib55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1074-7613(00)80591-9","article-title":"BLNK: a central linker protein in B cell activation","volume":"9","author":"Fu","year":"1998","journal-title":"Immunity"},{"issue":"23","key":"10.1016\/j.heliyon.2023.e17298_bib56","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1158\/1078-0432.CCR-15-1790","article-title":"The spectrum and clinical impact of epigenetic modifier mutations in Myeloma","volume":"22","author":"Pawlyn","year":"2016","journal-title":"Clin. Cancer Res"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e17298_bib57","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1182\/blood-2004-08-3096","article-title":"A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival","volume":"105","author":"Pearse","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e17298_bib58","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1586\/14737159.2015.1046436","article-title":"MET\/HGF pathway in multiple myeloma: from diagnosis to targeted therapy?","volume":"15","author":"Gambella","year":"2015","journal-title":"Expert Rev. Mol. Diagn"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e17298_bib59","first-page":"1365","article-title":"Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies","volume":"99","author":"Corral","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17298_bib60","doi-asserted-by":"crossref","first-page":"e0174835","DOI":"10.1371\/journal.pone.0174835","article-title":"Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK\/STAT3 pathway and the progression of the disease in multiple myeloma","volume":"E 12","author":"Beldi-Ferchiou","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e17298_bib61","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.transproceed.2004.09.046","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased frequency of Epstein-Barr Virus (EBV) latently infected B lymphocytes in long-term renal transplant patients","volume":"36","author":"N","year":"2004","journal-title":"Transplant. Proc"},{"key":"10.1016\/j.heliyon.2023.e17298_bib62","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fonc.2018.00665","article-title":"Deregulation and targeting of TP53 pathway in multiple myeloma","volume":"8","author":"Katarina","year":"2019","journal-title":"Front. Oncol"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17298_bib63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bone.2010.05.036","article-title":"TGF-\u03b2-related Mechanisms of Bone Destruction in Multiple Myeloma","volume":"48","author":"Toshio","year":"2011","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17298_bib64","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/PAS.0000000000000213","article-title":"MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS)","volume":"38","author":"Ruobing","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17298_bib65","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.leukres.2007.07.016","article-title":"CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis","volume":"32","author":"R\u00e9gis","year":"2008","journal-title":"Leuk. Res."},{"key":"10.1016\/j.heliyon.2023.e17298_bib66","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-019-1790-2","article-title":"MLLT3 governs human haematopoietic stem-cell self-renewal and engraftment","volume":"576","author":"Vincenzo","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17298_bib67","article-title":"The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression","volume":"2","author":"Asaf","year":"2014","journal-title":"Molecular & cellular oncology"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e17298_bib68","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1089\/gtmb.2016.0007","article-title":"Genetic association of PARP15 polymorphisms with clinical outcome of acute myeloid leukemia in a Korean population","volume":"20","author":"Min","year":"2016","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.heliyon.2023.e17298_bib69","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1471-2407-10-198","article-title":"Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays","volume":"10","author":"Kar\u00e8ne","year":"2010","journal-title":"BMC Cancer"},{"issue":"67","key":"10.1016\/j.heliyon.2023.e17298_bib70","first-page":"111213","volume":"8","author":"Xin","year":"2017","journal-title":"Oncotarget Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma"},{"key":"10.1016\/j.heliyon.2023.e17298_bib71","doi-asserted-by":"crossref","first-page":"117971","DOI":"10.1016\/j.lfs.2020.117971","article-title":"SR18292 exerts potent antitumor effects in multiple myeloma via inhibition of oxidative phosphorylation","volume":"256","author":"Yu","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.heliyon.2023.e17298_bib72","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fphar.2019.00038","article-title":"Dual tumor suppressor and tumor promoter action of sirtuins in determining malignant phenotype","volume":"10","author":"Vincenzo","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17298_bib73","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/s41388-019-1037-6","article-title":"Proteasome inhibitor induced SIRT1 deacetylates GLI2 to enhance hedgehog signaling activity and drug resistance in multiple myeloma","volume":"39","author":"Ying","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17298_bib74","first-page":"3","article-title":"Nup62\u2010mediated nuclear import of p63 in squamous cell carcinoma","volume":"19","author":"Joana","year":"2018","journal-title":"EMBO (Eur. Mol. Biol. Organ.) J."},{"issue":"27","key":"10.1016\/j.heliyon.2023.e17298_bib75","doi-asserted-by":"crossref","first-page":"19321","DOI":"10.1074\/jbc.M703222200","article-title":"Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62","volume":"282","author":"Yumei","year":"2007","journal-title":"J. Biol. Chem"},{"issue":"21","key":"10.1016\/j.heliyon.2023.e17298_bib76","first-page":"2587","volume":"127","author":"Ashujit","year":"2016","journal-title":"MUC1-C Drives MYC in Multiple Myeloma Blood"},{"issue":"13_Supplement","key":"10.1016\/j.heliyon.2023.e17298_bib77","first-page":"2498","volume":"78","author":"Tian","year":"2018","journal-title":"Over-expression of Dual-Specificity Phosphatase 4 (DUSP4) in Multiple Myeloma"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17298_bib78","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1365-2141.2003.04481.x","article-title":"Insights into extramedullary tumour cell growth revealed by expression profiling of human plasmacytomas and multiple myeloma","volume":"122","author":"Cyrus","year":"2003","journal-title":"Br. J. Haematol"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17298_bib79","first-page":"41","volume":"586","author":"Jian","year":"2016","journal-title":"SRPK2 Promotes the Growth and Migration of the Colon Cancer Cells Gene"},{"key":"10.1016\/j.heliyon.2023.e17298_bib80","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41591-018-0269-2","article-title":"Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma","volume":"24","author":"Guy","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2023.e17298_bib81","doi-asserted-by":"crossref","unstructured":"Federica A., Pezz\u00e8 L., Ciribilli Y., LAMPs: shedding light on cancer biology, Semin. Oncol. (2017).44(4):239-253.","DOI":"10.1053\/j.seminoncol.2017.10.013"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17298_bib82","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1261\/rna.055699.115","article-title":"Nudt3 Is an mRNA Decapping Enzyme that Modulates Cell Migration, 2016","volume":"22","author":"Ewa","year":"2016","journal-title":"Rna"},{"key":"10.1016\/j.heliyon.2023.e17298_bib83","doi-asserted-by":"crossref","unstructured":"Corinne C., et al., The THAP\u2013Zinc Finger Protein THAP1 Regulates Endothelial Cell Proliferation through Modulation of pRB\/E2F Cell-Cycle Target Genes Blood 2007.109(2):584-94.","DOI":"10.1182\/blood-2006-03-012013"},{"key":"10.1016\/j.heliyon.2023.e17298_bib84","doi-asserted-by":"crossref","unstructured":"Jane T., et al., RNF4-dependent oncogene activation by protein stabilization, Cell Rep. (2016).16(12):3388-3400.","DOI":"10.1016\/j.celrep.2016.08.024"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17298_bib85","first-page":"1377","article-title":"Low expression of KCNN3 may affect drug resistance in ovarian cancer","volume":"18","author":"Xia","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.heliyon.2023.e17298_bib86","doi-asserted-by":"crossref","unstructured":"Yu W., Ogawa M., Mu J., et al., IL-12- induced tumor regression correlates with in situ activity of IFN-gamma produced by tumor-infiltrating cells and its secondary induction of anti-tumor pathways, J. Leukoc. Biol. (1997).62(4):450-7.","DOI":"10.1002\/jlb.62.4.450"},{"key":"10.1016\/j.heliyon.2023.e17298_bib87","doi-asserted-by":"crossref","unstructured":"Dorina U., et al., Interferon \u03b3 is a strong, STAT1-dependent direct inducer of BCL6 expression in multiple myeloma cells, Biochem. Biophys. Res. Commun. (2018).498(3):502-508.","DOI":"10.1016\/j.bbrc.2018.03.010"},{"key":"10.1016\/j.heliyon.2023.e17298_bib88","doi-asserted-by":"crossref","unstructured":"Christina C., et al., Tumor cell responses to IFN\u03b3 affect tumorigenicity and response to IL-12 therapy and antiangiogenesis, Immunity (1998).9(1):25-34.","DOI":"10.1016\/S1074-7613(00)80585-3"},{"key":"10.1016\/j.heliyon.2023.e17298_bib89","doi-asserted-by":"crossref","unstructured":"Gareth M., Brian W., Faith D., The genetic architecture of multiple myeloma, Nat. Rev. Cancer (2012).12(5):335-48.","DOI":"10.1038\/nrc3257"},{"key":"10.1016\/j.heliyon.2023.e17298_bib90","doi-asserted-by":"crossref","unstructured":"Maria F., et al., Myeloma cells act as tolerogenic antigen\u2010presenting cells and induce regulatory T cells in vitro, Eur. J. Haematol. (2015).95(1):65-74.","DOI":"10.1111\/ejh.12481"},{"key":"10.1016\/j.heliyon.2023.e17298_bib91","doi-asserted-by":"crossref","unstructured":"Andrew C., et al., Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells, Br. J. Haematol. (2010).149(2):221-30.","DOI":"10.1111\/j.1365-2141.2009.08070.x"},{"key":"10.1016\/j.heliyon.2023.e17298_bib92","doi-asserted-by":"crossref","unstructured":"Roger P., et al., A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival, Blood (2005).105(11):4429-36.","DOI":"10.1182\/blood-2004-08-3096"},{"key":"10.1016\/j.heliyon.2023.e17298_bib93","doi-asserted-by":"crossref","unstructured":"Manuela G., et al., MET\/HGF pathway in multiple myeloma: from diagnosis to targeted therapy?, Expert Rev. Mol. Diagn. (2015).15(7):881-93.","DOI":"10.1586\/14737159.2015.1046436"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17298_bib94","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2013.08.002","article-title":"Dickkopf-1 is a key regulator of myeloma bone disease: opportunities and challenges for therapeutic intervention","volume":"27","author":"Fuling","year":"2013","journal-title":"Blood Rev"},{"key":"10.1016\/j.heliyon.2023.e17298_bib95","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1038\/onc.2012.448","article-title":"Poly (ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma","volume":"32","author":"Alessandro","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2023.e17298_bib96","doi-asserted-by":"crossref","unstructured":"Charlotte P., et al., The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma, Clinical cancer research, 2016.22(23):5783-5794.","DOI":"10.1158\/1078-0432.CCR-15-1790"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023045061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023045061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T19:12:19Z","timestamp":1766171539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023045061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":96,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2405844023045061"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17298","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of monoclonal gammopathy of undetermined significance progression to multiple myeloma through meta-analysis of GEO data","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e17298"}}